Cohort study

2,181 views 37 slides Jan 02, 2022
Slide 1
Slide 1 of 37
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37

About This Presentation

a scientific presentation about the types of cohort study for all the researchers


Slide Content

Dr. Faiza A. Abou El-Soud
Professor-Community Health Nursing
MenoufiyaUniversity-Egypt
Cohort Studies

✓To define the design of a cohort study
✓To identify features of cohort studies
✓To regonize the indications for cohort study
✓to determine the considerations during selection of cohort
✓To differentaite between the types of cohort study
✓To apply the elements of cohort study
✓To describe the strengths of cohort studies
✓To explain the weakness of cohort studies
✓To disucss biases in cohort study

Classification

•Persons banded together.
•Group of persons with a
common statistical
characteristic.
•Example,Age, birth date,

•Cohort is a group of people who
share common characteristicor
experience within the defined
period of time.
•Example,birth cohort, marriage
cohort, exposure cohort, etc.

•Cohorts are identified prior to appearance
of disease under investigation.
•The study groups are observed over a
period of time to determine the frequency
of diseaseamong them.
•The study proceeds from cause to effects.

here is good evidence of an association
between exposure and disease, from other
studies.
xposure is rare.
ttrition of study population can be minimized.

ufficient fund is available.

•Starts with people free of disease
•Assesses exposure at“baseline”
•Assesses disease status at “follow-up”
•Both the groups must be comparable in respect of
which influence the occurrence of disease.
•The exposed & non-exposed groups under study be as
as possible with regard to possible confounding
factors
•Both the groups should to disease
•Diagnostic and eligibility criteria of the disease must be
defined before hand.

rospective cohort study
etrospective (historical) cohort study
•Ambi-directional cohort Study
(Combination of Retrospective and)
Prospective cohort study.

•The common strategy of cohort studiesis to a reference population (or a
representative sample), some of whom have certain characteristics or attributes
relevant to the study (exposed group), with others who do not have those
characteristics (unexposed group).
•Both groups should, at the outset of the study, be free fromthe condition under
consideration.
•Both groupsare then observed over a specified periodto find out the risk each group
has of developing the condition(s) of interest.

•It is one in which the outcome have all occurred before the start of investigation.
•• Investigator goes back to the past to select study groupfrom existing records of
the past employment, medical and other records and traces them forwardthrough
time from the past date fixed on the records usually to the present

•Elements of prospective and retrospective
cohort are .
•The cohort is identified from past recordsand
assesses of data for the outcome.
•The same cohortis the followed upprospectively
into futurefor the further assessment of outcome.

I.Selection of study subjects
II.Selection of comparison group
III.Obtaining data on exposure
IV.Follow up
V.Analysis

•General population:
*Whole population in an area
*A representative sample
•Special group of population:
Select group
*Occupation group / professional group
Exposure groups
*Person having exposure to some physical,
chemical or biological agent
e.g.X-ray exposure to radiologists

Internal comparison
✓Only one cohortinvolved in study
✓Sub-classifiedand internal comparison done
External comparison
✓More than one cohortin the study for the purpose
of comparison
e.g.Cohort of radiologistcompared with
ophthalmologist

Comparison with general population rates
*If is available -we can
comparethe rates of study cohortwith
general population.
of with cancer in
general population

e.g., Dose of drug, radiation, type of surgery etc.
e.g.,Blood pressure, serum cholesterol
e.g.,Water, Air, Sanitation status etc.

•Follow up is the most critical partof the study-
To obtain data about outcome to be determined (morbidity
or mortality) through:
✓Mailed questionnaire, telephone calls, personal interviews
✓Periodic medical examination Reviewing records Surveillance
of death records
•Some loss to follow upis inevitable due to
•Loss to follow-up is one of the

1)Calculation of incidence ratesamong
and non exposedgroups
2)Estimation of risk:
✓RR (Relative Rate)
✓AR (Attributable risk)

(1)-Calculation of Incidence Rates

Calculation of Incidence Rates
Disease Status

Incidence Rates

(2)-Estimation of Risk
•is of an outcome in an
group to the probability of an outcome in an
group.
•is attributable to the exposure
factor in the epidemiological context,
•is the attributable to a
positive predictive result (e.g., lab test) in the clinical
context.

(2)-Estimation of Risk

(2)-Estimation of Risk

Example

Incidence Rates

Relative Risk = Rate Ratios
(RR)
Exposed Non-Exposed

Attributable Risk (AR)

Exercise ???
Thisprospectivecohortstudywasusedtoinvestigatetheeffects
ofhormonereplacementtherapy(HRT)oncoronaryartery
diseaseinpost-menopausalwomen.Theinvestigatorscalculated
theincidencerateofcoronaryarterydiseaseinpost-menopausal
womenwhohadbeentakingHRTandcomparedittothe
incidencerateinpost-menopausalwomenwhohadnottaken
HRT.Thefindingsaresummarizedinthistable:EstimateRR
andARwithyourinterpretation!

•Can establish population-based incidence
•Accurate relative risk (risk ratio) estimation
•Can examine rare exposures(asbestos > lung cancer)
•Can establish cause -effect
•Minimizes selection and information bias
•Can be used where randomization is not possible
• Magnitude of a risk factor’s effectcan be quantified
• More than one diseaserelated to single exposure
• Multiple outcomescan be studied (smoking > lung
cancer, COPD, larynx cancer)

•Often requires large sample
•Long timeto complete
•Expensive
•Ethical issues
•Non response, migration and loss-to-followup
biases
•Unexpected environmental changes may influence
the association

Differential loss of follow up
follow-up between compared groupsmay be
a major problem.
to follow-up due to study withdrawals,
unmeasured outcomes, or unknown reasons, are always
a concern.
Contamination Subjectsinitially unexposed to the risk
factor of interest may become exposed at a later date. Such
“ contamination ” tends to reduce the observed effect of the
risk factor.

Selection Bias
•The largest threat to the internal validity of a cohort
studies is selection bias, also called case-mix bias .
•Select participants into exposed and not exposed groups
based on some characteristics that may affect the outcome
Information bias
Collect different quality and extent of information from
exposed and not exposed groups.

Thank You